Charles Greg Guyer - 31 Dec 2021 Form 5 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
EVP, Chief Technical Officer
Signature
/s/ Eric Fleekop, Attorney-in-Fact
Issuer symbol
BMRN
Transactions as of
31 Dec 2021
Net transactions value
+$15,040
Form type
5
Filing time
11 Feb 2022, 20:51:34 UTC
Next filing
17 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Award $15,040 +241 +0.58% $62.41 41,936 29 Oct 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares acquired by the reporting person on October 29, 2021, pursuant to the issuer's Employee Stock Purchase Plan.